Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Reduce −9.6% | 9,467,383 | $83.52 | $791M | −1,000,000 | +$192M | |
| CEIXEUR - Consol Energy | Hold | 1,640,750 | $104.65 | $172M | — | — | |
| BHF - Brighthouse Finl | Reduce −2.7% | 2,892,049 | $45.03 | $130M | −80,982 | +$1M | |
| HPQ - HP | Add +4.7% | 3,530,890 | $35.87 | $127M | +157,860 | +$9M | |
| KD - Kyndryl | Add +11.0% | 4,924,349 | $22.98 | $113M | +488,530 | −$4M | |
| PENN - Penn Entertainment | Add +10.3% | 5,620,770 | $18.86 | $106M | +525,430 | +$7M | |
| LBTYA - Liberty Global · CL A | Add +108.3% | 4,252,880 | $21.11 | $90M | +2,211,300 | +$54M | |
| ALITEUR - Alight · CL A | Add +7.0% | 11,846,210 | $7.40 | $88M | +772,120 | +$6M | |
| VTRS - Viatris | Reduce −1.7% | 7,270,430 | $11.61 | $84M | −129,380 | +$6M | |
| CNH - Cnh Indl | New | 7,096,900 | $11.10 | $79M | +7,096,900 | +$79M | |
| ROIV - Roivant Sciences | Add +10.3% | 5,308,040 | $11.54 | $61M | +497,080 | +$10M | |
| TECK - Teck Resources · CL B | Hold | 1,086,663 | $52.24 | $57M | — | — | |
| GLD - Spdr Gold Tr | Add +3.1% | 208,681 | $243.06 | $51M | +6,350 | +$7M | |
| DHT — | Add +7.9% | 4,343,280 | $11.03 | $48M | +318,940 | +$1M | |
| THC - Tenet Healthcare | Reduce −52.0% | 287,100 | $166.20 | $48M | −310,577 | −$32M | |
| ODP1 - The Odp | Reduce −28.0% | 1,600,000 | $29.75 | $48M | −622,470 | −$40M | |
| CPRI - Capri | Add +58.7% | 1,086,645 | $42.44 | $46M | +401,875 | +$23M | |
| PTON - Peloton Interactive · CL A | Add +40.4% | 9,529,890 | $4.68 | $45M | +2,740,750 | +$22M | |
| IAC - IAC Inc | Add +118.3% | 636,270 | $53.82 | $34M | +344,810 | +$21M | |
| LIVN - Livanova | Reduce −6.3% | 603,549 | $52.54 | $32M | −40,720 | −$4M | |
| PKG - Graphic Packaging | Reduce −25.0% | 1,047,100 | $29.59 | $31M | −349,030 | −$6M | |
| SDRL - Seadrill 2021 | Add +5.6% | 601,545 | $39.74 | $24M | +32,140 | −$5M | |
| RSP — | Hold | 182,511 | $114.97 | $21M | — | — | |
| XAR - Spdr Ser Tr | Hold | 127,557 | $157.34 | $20M | — | — | |
| WFRD - Weatherford Intl | Hold | 177,339 | $84.92 | $15M | — | — | |
| LKFT - Galapagos | Add +104.1% | 479,363 | $28.79 | $14M | +244,535 | +$8M | |
| COYA - Coya Therapeutics | Hold | 1,274,026 | $6.45 | $8M | — | — | |
| TEVA - Teva Pharmaceutical Inds | Hold | 324,850 | $18.02 | $6M | — | — | |
| GDX - Vaneck ETF Trust | Hold | 111,390 | $39.82 | $4M | — | — | |
| GPRO - Gopro · CL A | Hold | 2,823,100 | $1.36 | $4M | — | — | |
| OIH - Vaneck ETF Trust | Hold | 11,220 | $283.71 | $3M | — | — | |
| FCG - First Tr Exchange-Traded Fd | Hold | 70,830 | $23.75 | $2M | — | — | |
| IVZ - Invesco Actvely Mngd Etc Fd | Hold | 117,360 | $13.43 | $2M | — | — | |
| GANX - Gain Therapeutics | Hold | 566,130 | $1.78 | $1M | — | — | |
| Danimer Scientific · CL A | Reduce −59.9% | 1,097,461 | $0.4542 | $498K | −1,637,119 | −$1M | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $2.29 | $80K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2024 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| SHC - Sotera Health | Exit | 0 | $11.87 | $4M | −300,110 | −$4M | |
| TLIS - Talis Biomedical | Exit | 0 | $8.66 | $1M | −149,052 | −$1M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2